Australia markets closed

Percheron Therapeutics Limited (ATHJF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
At close: 02:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
10,162
10,162
4,535
4,913
1,899
Selling general and administrative
3,054
3,054
2,921
3,556
4,456
Total operating expenses
13,345
13,345
7,611
8,683
6,666
Operating income or loss
-13,345
-13,345
-7,611
-8,683
-6,666
Total other income/expenses net
1,588
1,588
1,777
629.195
740.099
Income before tax
-11,380
-11,380
-5,812
-8,061
-5,908
Income tax expense
0
0
0
0
0
Income from continuing operations
-11,380
-11,380
-5,812
-8,061
-5,908
Net income
-11,380
-11,380
-5,812
-8,061
-5,908
Net income available to common shareholders
-11,380
-11,380
-5,812
-8,061
-5,908
Basic EPS
-0.02
-0.02
-0.01
-0.01
-0.01
Diluted EPS
-0.02
-0.02
-0.01
-0.01
-0.01
Basic average shares
669,029
669,029
634,294
540,980
455,834
Diluted average shares
669,029
669,029
634,294
540,980
455,834